Fredun Pharmaceuticals Ltd — Important, 29-11-2025: Company Update

Fredun Pharmaceuticals has released updated details regarding its preferential share and warrant issue, enhancing transparency for shareholders. The company disclosed Ultimate Beneficial Owners and pre-preferential shareholding of allottees. Crucially, it outlined the utilization of 153.25 Cr from the issue. Funds will be deployed across brand marketing, CAPEX, R&D, and working capital. This capital fuels a strategic expansion into Integrated Health, Wellness, and Pharmaceutical divisions, including Pet Care, Human Care, and Pharma Generics, aiming to build a diversified and sustainable healthcare business across new international markets.